Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023

Rhea-AI Summary

Cara Therapeutics will host a conference call and webcast on August 7, 2023, to report second quarter 2023 financial results and provide a corporate update. Registrants can participate in the call and access the webcast through the Company's website.

STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, August 7, 2023, at 4:30 p.m. ET to report second quarter 2023 financial results and provide a corporate update.

To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN.

A live audio webcast and archived replay of the call will be available under “Events & Presentations” in the Investors section of the Company’s website at www.CaraTherapeutics.com.

About Cara Therapeutics

Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s KORSUVA® (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has Phase 3 programs ongoing for the treatment of pruritus in patients with advanced chronic kidney disease and atopic dermatitis. In addition, the Company has initiated a Phase 2/3 program of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica. For more information, visit www.CaraTherapeutics.com and follow the company on Twitter, LinkedIn and Instagram.

MEDIA CONTACT:
Annie Spinetta
6 Degrees
973-768-2170
aspinetta@6degreespr.com

INVESTOR CONTACT:
Iris Francesconi, Ph.D.
Cara Therapeutics
203-406-3700
investor@caratherapeutics.com

 

FAQ

When will Cara Therapeutics host a conference call and webcast?

Cara Therapeutics will host a conference call and webcast on Monday, August 7, 2023.

What is the purpose of the conference call and webcast?

The purpose of the conference call and webcast is to report second quarter 2023 financial results and provide a corporate update.

How can I participate in the conference call?

To participate in the conference call, you need to register on the Company's website.

Where can I access the webcast?

The webcast will be available under 'Events & Presentations' in the Investors section of the Company's website.